Dysregulated expression of MIC-1/PDF in human prostate tumor cells

被引:70
作者
Karan, D
Chen, SJ
Johansson, SL
Singh, AP
Paralkar, VM
Lin, MF
Batra, SK
机构
[1] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA
[3] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA
[4] Pfizer Inc, Groton, CT 06340 USA
[5] Univ Nebraska, Med Ctr, Dept Surg, Urol Sect, Omaha, NE USA
关键词
LNCaP cell model; MIC-1/PDF; prostate cancer; immunohistochemistry;
D O I
10.1016/S0006-291X(03)00823-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As a part of the study to identify genes associated with hormone-refractory stage of human prostate cancer, we have recently identified several genetic and epigenetic changes that seem to be associated with the progression of androgen-sensitive to androgen-independent prostate tumor cells. In the present study, we report a novel gene, macrophage inhibitory cytokine-1 (MIC-1) also known as prostate derived factor (PDT), that was highly expressed in androgen-independent LNCaP-C81 cells and its metastatic variant LNCaP-Ln3 compared to androgen-sensitive LNCaP-C33 cells. The MIC-1/PDF expression was dysregulated (very low to non-detectable) in the androgen-independent PC3 and DU145 cells. Interestingly, serum factors demonstrated a differential regulation of MIC-1/PDF in the androgen-sensitive and the androgen-independent cells of LNCaP cells. Immunohistochemical analysis on 15 prostatic adenocarcinomas showed a weak staining in the benign prostatic glandular area (intensity score 2.38 +/- 0.25; n = 13), while the immunoreactivity was significantly stronger (p < 0.05) in areas of adenocarcinoma (score 7.33 +/- 0.88; n = 15). Altogether, these data suggest that the serum factors (including androgens and cytokines) might contribute to the regulation of the MIC-1/PDF gene that seems to be associated with the progression of prostate cancer. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:598 / 604
页数:7
相关论文
共 28 条
[1]  
Barrack ER, 1997, PROSTATE, V31, P61
[2]  
BATRA SK, 1991, J CELL SCI, V100, P841
[3]   MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily [J].
Bootcov, MR ;
Bauskin, AR ;
Valenzuela, SM ;
Moore, AG ;
Bansal, M ;
He, XY ;
Zhang, HP ;
Donnellan, M ;
Mahler, S ;
Pryor, K ;
Walsh, BJ ;
Nicholson, RC ;
Fairlie, WD ;
Por, SB ;
Robbins, JM ;
Breit, SN .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (21) :11514-11519
[4]   Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study [J].
Brown, DA ;
Breit, SN ;
Buring, J ;
Fairlie, WD ;
Bauskin, AR ;
Liu, T ;
Ridker, PM .
LANCET, 2002, 359 (9324) :2159-2163
[5]  
Buckhaults P, 2001, CANCER RES, V61, P6996
[6]   Androgen receptors in prostate cancer [J].
Culig, Z ;
Klocker, H ;
Bartsch, G ;
Hobisch, A .
ENDOCRINE-RELATED CANCER, 2002, 9 (03) :155-170
[7]   THE ENDOCRINOLOGY AND DEVELOPMENTAL BIOLOGY OF THE PROSTATE [J].
CUNHA, GR ;
DONJACOUR, AA ;
COOKE, PS ;
MEE, S ;
BIGSBY, RM ;
HIGGINS, SJ ;
SUGIMURA, Y .
ENDOCRINE REVIEWS, 1987, 8 (03) :338-362
[8]   MIC-1 is a novel TGF-β superfamily cytokine associated with macrophage activation [J].
Fairlie, WD ;
Moore, AG ;
Bauskin, AR ;
Russell, PK ;
Zhang, HP ;
Breit, SN .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 65 (01) :2-5
[9]   The development of androgen-independent prostate cancer [J].
Feldman, BJ ;
Feldman, D .
NATURE REVIEWS CANCER, 2001, 1 (01) :34-45
[10]  
FLEMING ID, 1997, AJCC CANC STAINING M, P1